Go offline with the Player FM app!
Ovarian Cancer
Manage episode 367326026 series 3461892
With Dr. Barbara Vanderhyden, Corinne Boyer Chair in Ovarian Cancer Research at the University of Ottawa. Like many things related to sexual and reproductive health, there’s elevated stigma about gynecological cancers. Like many health issues for women, girls, and gender-diverse people, there are serious gaps in knowledge and treatment, too. The gaps are bigger for those who face discrimination based on factors like race, ability, and income.
It’s ironic that modern biological research is based on cells taken from a woman named Henreitta Lacks in 1951 at Johns Hopkins Hospital. Lacks was a Black woman diagnosed with cervical cancer. Her cells were taken without her consent and cultivated into the HeLa cell line, the most commonly used cell line in scientific research today.
Those most marginalized, dealing with the poorest treatment and outcomes and most stigmatized and understudied health issues are the ones we’ve built our medical practices on.
Since May 28, International Day of Action for Women's Health, we’ve focused on gender and health matters we may know bits and pieces of but probably need to learn more about. As we wrap up this mini-series, we can’t help but take a long view of equality, justice, and rights in medicine. We’re thankful to the amazing medical scientists trying to turn the tide today.
Our guest Dr. Barbara Vanderhyden is one of those people. She’s the inaugural Corinne Boyer Chair in Ovarian Cancer Research at the University of Ottawa and a Senior Scientist in the Cancer Therapeutics Program at the Ottawa Hospital Research Institute. She loves talking about her research, which focuses on how risk factors affect the incidence of ovarian cancer, and how good models of ovarian cancer can shed light on cancer susceptibility, tumour progression and response to treatment. Dr. Vanderhyden teaches about science, academic integrity, and science communication.
Relevant links: Ovarian Cancer Canada
Please listen, subscribe, rate, and review this podcast and share it with others. If you appreciate this content, if you want to get in on the efforts to build a gender equal Canada, please donate at canadianwomen.org and consider becoming a monthly donor.
Episode Transcripts
Facebook: Canadian Women’s Foundation
Twitter: @cdnwomenfdn
LinkedIn: The Canadian Women’s Foundation
Instagram: @canadianwomensfoundation
109 episodes
Manage episode 367326026 series 3461892
With Dr. Barbara Vanderhyden, Corinne Boyer Chair in Ovarian Cancer Research at the University of Ottawa. Like many things related to sexual and reproductive health, there’s elevated stigma about gynecological cancers. Like many health issues for women, girls, and gender-diverse people, there are serious gaps in knowledge and treatment, too. The gaps are bigger for those who face discrimination based on factors like race, ability, and income.
It’s ironic that modern biological research is based on cells taken from a woman named Henreitta Lacks in 1951 at Johns Hopkins Hospital. Lacks was a Black woman diagnosed with cervical cancer. Her cells were taken without her consent and cultivated into the HeLa cell line, the most commonly used cell line in scientific research today.
Those most marginalized, dealing with the poorest treatment and outcomes and most stigmatized and understudied health issues are the ones we’ve built our medical practices on.
Since May 28, International Day of Action for Women's Health, we’ve focused on gender and health matters we may know bits and pieces of but probably need to learn more about. As we wrap up this mini-series, we can’t help but take a long view of equality, justice, and rights in medicine. We’re thankful to the amazing medical scientists trying to turn the tide today.
Our guest Dr. Barbara Vanderhyden is one of those people. She’s the inaugural Corinne Boyer Chair in Ovarian Cancer Research at the University of Ottawa and a Senior Scientist in the Cancer Therapeutics Program at the Ottawa Hospital Research Institute. She loves talking about her research, which focuses on how risk factors affect the incidence of ovarian cancer, and how good models of ovarian cancer can shed light on cancer susceptibility, tumour progression and response to treatment. Dr. Vanderhyden teaches about science, academic integrity, and science communication.
Relevant links: Ovarian Cancer Canada
Please listen, subscribe, rate, and review this podcast and share it with others. If you appreciate this content, if you want to get in on the efforts to build a gender equal Canada, please donate at canadianwomen.org and consider becoming a monthly donor.
Episode Transcripts
Facebook: Canadian Women’s Foundation
Twitter: @cdnwomenfdn
LinkedIn: The Canadian Women’s Foundation
Instagram: @canadianwomensfoundation
109 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.